Jericho, i couldn't agree more. The risk/reward of a new pharmaceutical company with a solid technology, a fabulous joint venture with a highly respected medical research center, no toxic debt on the books, and run by men with previous business successes on their resume, is enticing to me.
Yes i could lose my entire investment. But this could also pop hard on good news and perhaps 25+ times on signed tech licensing agreements. It is hard to see a future where this continues trading in the $3 to $5 range.
Something very interesting will happen here and i'm happy to be sitting in the front row with a bag of popcorn.
News 
Market Data 
Discover 
